搜索临床试验以:Blastic Plasmacytoid Dendritic Cell Neoplasm
总计120728个结果
-
Hadassah Medical Organization未知
-
Nabi Biopharmaceuticals完全的
-
University of MilanFondazione Humanitas per la Ricerca完全的
-
The Parkinson Study GroupWyeth is now a wholly owned subsidiary of Pfizer; Joseph and Rosalyn Newman Foundation完全的
-
Medical University of Vienna未知Allogeneic Hematopoietic Cell Transplant Recipients奥地利, 捷克共和国
-
NSABP Foundation IncAmgen撤销
-
Celtic Pharma Development ServicesNeurobiological Technologies撤销
-
Massachusetts General HospitalEli Lilly and Company; GlaxoSmithKline完全的
-
University of California, Davis完全的
-
The Netherlands Cancer InstituteDutch Cancer Society未知因治疗引起的主诉的乳腺癌患者的更年期症状
-
University Hospital, Ghent完全的
-
National Institute of Arthritis and Musculoskeletal...University of Pittsburgh; Genzyme, a Sanofi Company; Amgen终止
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Amarin Neuroscience LtdHuntington Study Group完全的
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.未知
-
Amgen完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; United States Department... 和其他合作者完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and... 和其他合作者完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Cellectar Biosciences, Inc.完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Beth Israel Deaconess Medical Center; Brigham...完全的
-
Fred Hutchinson Cancer CenterNational Institutes of Health (NIH); Burroughs Wellcome完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的